Invasive procedure a breath of fresh air for asthma patients

COIMBATORE: Ramakrishnan, a senior citizen from Pappampati Pirivu and an asthmatic, was afraid to ride bicycles or even step out before 8.30am during the winter. Fearing an asthma attack, he avoided bus rides. Even his reliever inhaler could not control the bouts of wheezing, often forcing him to spend a day in hospital.

But after undergoing bronchial thermoplasty in June last year, Ramakrishnan’s life has changed dramatically. “For the last one year, I have been cycling even up to 10km and going out early in the mornings even on cold and misty days,” he told TOI.

Bronchial thermoplasty involves a doctor guiding a catheter into the windpipe to see air passages. The instrument raises the temperature in the airways using therapeutic radio frequency energy for 10 seconds to shrink the muscle so that they don’t swell during asthma attack and restrict breathing.

Three patients, who underwent the invasive procedure a year ago, met at Royal Care Hospital to discuss about the asthma-free life. “They still need inhalers and take precautions after the treatment. But it definitely removed hospitalization and the need for more steroids,” said pulmonologist Dr V R Pattabhiraman.

Ramakrishnan is among the 10% of asthma patients in the district, who suffer from severe asthma. “In Coimbatore, almost 10% of asthma patients suffer from sever asthma, where inhalers do not help. They require hospitalization almost twice or thrice a year and higher doses of oral steroids. It is for these patients that thermoplasty helps,” the doctor said.

  • Related Posts

    Lilly launches Mounjaro KwikPen in India

    Mumbai, August 14, 2025 — Eli Lilly and Company (India) has rolled out the Mounjaro (tirzepatide) KwikPen across the country, expanding treatment choices for people with type-2 diabetes and those…

    Fortis Q1 Profit Jumps 57%; Expansion Drives Growth

      Gurugram, August 7 – http://Fortis HealthcareFortis Healthcare has reported a 57% year-on-year increase in its net profit for the first quarter of FY2025. The hospital chain posted ₹260 crore…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    GSK Pharma forays into gynaecological cancer treatment in India

    GSK Pharma forays into gynaecological cancer treatment in India

    Hyderabad rising in biotech, pharma, medtech innovation: Revanth Reddy

    Hyderabad rising in biotech, pharma, medtech innovation: Revanth Reddy

    DCGI issued alert regarding theft of Novo Nordisk injectables

    DCGI issued alert regarding theft of Novo Nordisk injectables

    Two firms fined for selling spurious cosmetic products

    Two firms fined for selling spurious cosmetic products